Deep Venous Thrombosis

  • Fahad S. Alasfar
  • Dwayne Badgett
  • Anthony J. Comerota

Case Report

A 67-year-old male had a history of a right calf deep venous thrombosis (DVT) following a flight from California to New York. He was treated on that occasion with anticoagulation with unfractionated heparin then Coumadin for 3 months. Recently, he was diagnosed with sigmoid cancer. He is now on postoperative day 3 from exploratory laparotomy, sigmoid colectomy and extensive lysis of adhesions. Although he was haemodynamically stable, he required a transfusion of three units of blood. DVT prophylaxis for the perioperative period included graded knee-high compressive stockings and intermittent pneumatic compression (IPC).

Question 1

What are the risk factors that predispose to DVT?

Question 2

What is the clinical presentation of a patient with anti-thrombin III (ATIII) deficiency?

Question 3

Regarding antiphospholipid antibody (APA) syndrome, which of the following is not correct?
  1. A.

    Procainamide has been associated with the development of APA syndrome.

  2. B.



  1. 1.
    Kistner RL, Ball JJ, Nordyke RA, Freeman GC. Incidence of pulmonary embolism in the course of thrombophlebitis. Am J Surg. 1972;124:169–76.CrossRefPubMedGoogle Scholar
  2. 2.
    Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopaedic, and urologic surgery. N Engl J Med. 1988;318:1162–73.CrossRefPubMedGoogle Scholar
  3. 3.
    Masuda EM, Kessler DM, Kistner RL, Eklof B, Sato DT. The natural history of calf vein thrombosis: lysis of thrombi and development of reflux. J Vasc Surg. 1998;28:67–74.CrossRefPubMedGoogle Scholar
  4. 4.
    Lechner K, Pabinger-Fasching I. Lupus anticoagulant and thrombosis: a study of 25 cases and review of the literature. Haemostasis. 1985;15:254–62.PubMedGoogle Scholar
  5. 5.
    Baker WH, Potthoff WP, Biller J, McCoyd K. Carotid artery thrombosis associated with lupus anticoagulant. Surgery. 1985;98:612–5.PubMedGoogle Scholar
  6. 6.
    Li GC, Greenberg CS, Currie MS. Procainamide-induced lupus anticoagulant and thrombosis. South Med J. 1988;81:262–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Asherson RA, Chan JK, Harris EN, Gharavi AE, Hughes GR. Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann Rheum Dis. 1985;44:823–5.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332:993–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Hirsh DR, Mikkola KM, Marks PW, et al. PE and DVT during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Am Heart J. 1996;131:1145–8.CrossRefGoogle Scholar
  11. 11.
    Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V mutation. Ann Intern Med. 1997;126:528–31.CrossRefPubMedGoogle Scholar
  12. 12.
    Cushman M, Rosendaal FR, Psaty BM, Factor V. Leiden is not a risk factor for arterial vascular disease in the elderly: result from the cardiovascular health study. Thromb Haemost. 1998;79:912–5.PubMedGoogle Scholar
  13. 13.
    Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S–75S.CrossRefPubMedGoogle Scholar
  14. 14.
    Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg. 1988;208:227–40.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Nicolaides AN, Miles C, Hoare M, Jury P, Helmis E, Venniker R. Intermittent sequential pneumatic compression of the legs and thromboembolism-deterrent stockings in the prevention of postoperative deep venous thrombosis. Surgery. 1983;94:21–5.PubMedGoogle Scholar
  17. 17.
    Hoek JA, Nurmohamed MT, Hamelynck KJ, et al. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost. 1992;67:28–32.PubMedGoogle Scholar
  18. 18.
    Turpie AG, Levine MN, Hirsh J, et al. A randomized controlled trial of low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986;315:925–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331:1601–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Waring WP, Karunas RS. Acute spinal cord injuries and the incidence of clinically occurring thromboembolic disease. Paraplegia. 1991;29:8–16.PubMedGoogle Scholar
  21. 21.
    Myllynen P, Kammonen M, Rokkanen P, Bostman O, Lalla M, Laasonen E. Deep venous thrombosis and pulmonary embolism in patients with acute spinal cord injury: a comparison with nonparalysed patients immobilized due to spinal fractures. J Trauma. 1985;25:541–3.CrossRefPubMedGoogle Scholar
  22. 22.
    Warkentin TE. Heparin-induced thrombocytopenia: a ten-year retrospective. Ann Rev Med. 1999;50:129.CrossRefPubMedGoogle Scholar
  23. 23.
    Magnani HN. Heparin induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost. 1993;70:554.PubMedGoogle Scholar
  24. 24.
    Greinacher A, Janssens U, Berg G, et al. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation. 1999;100:587–93.CrossRefPubMedGoogle Scholar
  25. 25.
    Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409–15.CrossRefPubMedGoogle Scholar
  26. 26.
    Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters: indications, safety, effectiveness. Arch Intern Med. 1992;152:1985–94.CrossRefPubMedGoogle Scholar
  27. 27.
    Duckert F, Muller G, Nyman D, et al. Treatment of deep vein thrombosis with streptokinase. BMJ. 1975;1:479–81.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000;32:130–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Fahad S. Alasfar
    • 1
  • Dwayne Badgett
    • 1
  • Anthony J. Comerota
    • 1
  1. 1.Department of SurgeryTemple University HospitalPhiladelphiaUSA

Personalised recommendations